RNA therapeutics: beyond RNA interference and antisense oligonucleotides

Continuous cultures of fused cells secreting antibody of predefined specificity

Köhler, G., & Milstein, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,200 · see citing works

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429 · see citing works

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456 · see citing works

Identification and characterization of a spinal muscular atrophy-determining gene

Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Bénichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,995 · see citing works

Drug-like properties and the causes of poor solubility and poor permeability

Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,776 · see citing works

RNA sequencing: advances, challenges and opportunities

Ozsolak, F., & Milos, P. M. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2934 · Cited by 2,135 · see citing works

Rational design of cationic lipids for siRNA delivery

Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822 · see citing works

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.

Zamecnik, P. C., & Stephenson, M. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.280 · Cited by 1,792 · see citing works

X chromosome-linked muscular dystrophy (mdx) in the mouse

Bulfield, G., Siller, W. G., Wight, P. A., & Moore, K. J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.4.1189 · Cited by 1,765 · see citing works

A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy

Lorson, C. L., Hahnen, E., Androphy, E. J., & Wirth, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6307 · Cited by 1,536 · see citing works

Spliced segments at the 5′ terminus of adenovirus 2 late mRNA

Berget, S. M., Moore, C. L., & Sharp, P. A. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.8.3171 · Cited by 1,424 · see citing works

Therapeutic potential of Toll-like receptor 9 activation

Krieg, A. Μ. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,244 · see citing works

An amazing sequence arrangement at the 5′ ends of adenovirus 2 messenger RNA

Chow, L. T., Gelinas, R. E., Broker, T. R., & Roberts, R. J. (1977) · Cell · doi:10.1016/0092-8674(77)90180-5 · Cited by 1,234 · see citing works

Interfering with disease: a progress report on siRNA-based therapeutics

de Fougerolles, A., Vornlocher, H., Maraganore, J. M., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,202 · see citing works

Dystrophin and mutations: one gene, several proteins, multiple phenotypes

Francesco Muntoni, A., Torelli, S., & Ferlini, A. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00585-4 · Cited by 1,124 · see citing works

RNA interference targeting Fas protects mice from fulminant hepatitis

Song, E., Lee, S., Wang, J., Ince, M. N., Ouyang, N., Min, J., Chen, J., Shankar, P., & Lieberman, J. (2003) · Nature Medicine · doi:10.1038/nm828 · Cited by 1,112 · see citing works

Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application

Jackson, A. L., & Linsley, P. S. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd3010 · Cited by 1,092 · see citing works

The Thalassaemia Syndromes

Weatherall, D. J., & Clegg, J. B. (2001) · Wiley eBooks · doi:10.1002/9780470696705 · Cited by 1,077 · see citing works

Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy

Miller, J. W., Urbinati, C. R., Teng‐umnuay, P., Stenberg, M. G., Byrne, B. J., Thornton, C. A., & Swanson, M. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4439 · Cited by 937 · see citing works

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

Raal, F. J., Santos, R. D., Blom, D. J., Marais, A. D., Charng, M., Cromwell, W. C., Lachmann, R., Gaudet, D., Tan, J. L., Chasan-Taber, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60284-x · Cited by 921 · see citing works

Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide.

Stephenson, M. L., & Zamecnik, P. C. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.285 · Cited by 904 · see citing works

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

Çırak, S., Arechavala‐Gomeza, V., Guglieri, M., Feng, L., Torelli, S., Anthony, K., Abbs, S. J., Garralda, M. E., Bourke, J. P., Wells, D. J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60756-3 · Cited by 879 · see citing works

Local Dystrophin Restoration with Antisense Oligonucleotide PRO051

van Deutekom, J. C., Janson, A. A. M., Ginjaar, I. B., Frankhuizen, W. S., Aartsma-Rus, A. M., Bremmer-Bout, M., den Dunnen, J. T., Koop, K., van der Kooi, A. J., Goemans, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073108 · Cited by 780 · see citing works

Current prospects for RNA interference-based therapies

Davidson, B. L., & McCray, P. B. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2968 · Cited by 760 · see citing works

Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model

Hua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C. F., & Krainer, A. R. (2011) · Nature · doi:10.1038/nature10485 · Cited by 744 · see citing works

Beta-thalassemia

Cao, A., & Galanello, R. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181cd68ed · Cited by 722 · see citing works

Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy

Goemans, N., Tulinius, M., van den Akker, J. T., Burm, B. E. A., Ekhart, P. F., Heuvelmans, N., Holling, T. M., Janson, A. A. M., Platenburg, G. J., Sipkens, J. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011367 · Cited by 678 · see citing works

Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse modelPreprint

Hua, Y., Sahashi, K., Hung, G., Rigo, F., Passini, M. A., Bennett, C. F., & Krainer, A. R. (2010) · Genes & Development · doi:10.1101/gad.1941310 · Cited by 665 · see citing works

Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study

Kinali, M., Arechavala‐Gomeza, V., Feng, L., Çırak, S., Hunt, D. M., Adkin, C. F., Guglieri, M., Ashton, E., Abbs, S. J., Nihoyannopoulos, P., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70211-x · Cited by 653 · see citing works

Immunotherapy: past, present and future

Waldmann, T. A. (2003) · Nature Medicine · doi:10.1038/nm0303-269 · Cited by 623 · see citing works

Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations

Aartsma-Rus, A. M., Fokkema, I. F. A. C., Verschuuren, J. J. G. M., Ginjaar, I. B., van Deutekom, J. C. T., van Ommen, G. B., & den Dunnen, J. T. (2009) · Human Mutation · doi:10.1002/humu.20918 · Cited by 576 · see citing works

Antisense Masking of an hnRNP A1/A2 Intronic Splicing Silencer Corrects SMN2 Splicing in Transgenic Mice

Hua, Y., Vickers, T. A., Okunola, H. L., Bennett, C. F., & Krainer, A. R. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.01.014 · Cited by 576 · see citing works

Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy

Passini, M. A., Bu, J., Richards, A. M., Kinnecom, C., Sardi, S. P., Stanek, L. M., Hua, Y., Rigo, F., Matson, J. E., Hung, G., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001777 · Cited by 547 · see citing works

Alternative splicing and disease

Tazi, J., Bakkour, N., & Stamm, S. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.09.017 · Cited by 541 · see citing works

Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.

Matsukura, M., Shinozuka, K., Zon, G., Mitsuya, H., Reitz, M. S., Cohen, J. S., & Broder, S. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7706 · Cited by 533 · see citing works

Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology

Alter, J., Lou, F., Rabinowitz, A. H., Yin, H., Rosenfeld, J., Wilton, S. D., Partridge, T. A., & Lu, Q. L. (2006) · Nature Medicine · doi:10.1038/nm1345 · Cited by 494 · see citing works

Splicing of a Critical Exon of Human Survival Motor Neuron Is Regulated by a Unique Silencer Element Located in the Last Intron

Singh, N. K., Singh, N. N., Androphy, E. J., & Singh, R. N. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1333-1346.2006 · Cited by 452 · see citing works

Chemically modified siRNA: tools and applications

Watts, J. K., Deleavey, G. F., & Damha, M. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.05.007 · Cited by 431 · see citing works

Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides.

Domiński, Z., & Kole, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8673 · Cited by 426 · see citing works

Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles

Lu, Q. L., Rabinowitz, A. H., Chen, Y. C., Yokota, T., Yin, H., Alter, J., Jadoon, A., Bou–Gharios, G., & Partridge, T. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406700102 · Cited by 402 · see citing works

Efficacy of systemic morpholino exon‐skipping in duchenne dystrophy dogs

Yokota, T., Lu, Q., Partridge, T. A., Kobayashi, M., Nakamura, A., Takeda, S., & Hoffman, E. P. (2009) · Annals of Neurology · doi:10.1002/ana.21627 · Cited by 398 · see citing works

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse

Lu, Q. L., Mann, C. J., Lou, F., Bou–Gharios, G., Morris, G. E., Xue, S., Fletcher, S., Partridge, T. A., & Wilton, S. D. (2003) · Nature Medicine · doi:10.1038/nm897 · Cited by 398 · see citing works

Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA

Wheeler, T. M., Sobczak, K., Lueck, J. D., Osborne, R. J., Lin, X., Dirksen, R. T., & Thornton, C. A. (2009) · Science · doi:10.1126/science.1173110 · Cited by 387 · see citing works

Enhancement of SMN2 Exon 7 Inclusion by Antisense Oligonucleotides Targeting the Exon

Hua, Y., Vickers, T. A., Baker, B. F., Bennett, C. F., & Krainer, A. R. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050073 · Cited by 340 · see citing works

Pathogenic mechanisms of myotonic dystrophy

Lee, J. E., & Cooper, T. A. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371281 · Cited by 307 · see citing works

Systemically delivered antisense oligomers upregulate gene expression in mouse tissues

Sazani, P., Gemignani, F., Kang, S.-H., Maier, M. A., Manoharan, M., Persmark, M., Bortner, D. M., & Kole, R. (2002) · Nature Biotechnology · doi:10.1038/nbt759 · Cited by 301 · see citing works

Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.

Smith, C. C., Aurelian, L., Reddy, M. P., Miller, P. S., & Ts’o, P. O. P. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2787 · Cited by 297 · see citing works

Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells

van Deutekom, J. C. T. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.15.1547 · Cited by 293 · see citing works

Antisense Drug Technology

(2010) · CRC Press eBooks · doi:10.1201/9781420002546 · Cited by 270 · see citing works

Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy

Mulders, S. A. M., van den Broek, W. J. A. A., Wheeler, T. M., Croes, H. J. E., van Kuik‐Romeijn, P., de Kimpe, S. J., Furling, D., Platenburg, G. J., Gourdon, G., Thornton, C. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905780106 · Cited by 257 · see citing works

Does antisense exist?

Stein, C. A. (1995) · Nature Medicine · doi:10.1038/nm1195-1119 · Cited by 250 · see citing works

Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)

DeVincenzo, J. P., Cehelsky, J., Alvarez, R., Elbashir, S. M., Harborth, J., Toudjarska, I., Nechev, L. V., Murugaiah, V., VLIET, A., & Vaishnaw, A. K. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2007.11.009 · Cited by 247 · see citing works

Sustained Dystrophin Expression Induced by Peptide-conjugated Morpholino Oligomers in the Muscles of mdx Mice

Jearawiriyapaisarn, N., Moulton, H. M., Buckley, B. K., Roberts, J., Sazani, P., Fucharoen, S., Iversen, P. L., & Kole, R. (2008) · Molecular Therapy · doi:10.1038/mt.2008.120 · Cited by 245 · see citing works

Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer

Wu, B., Moulton, H. M., Iversen, P. L., Jiang, J., Li, J., Li, J., Spurney, C. F., Sali, A., Guerron, A. D., Nagaraju, K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805676105 · Cited by 237 · see citing works

Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer

Chi, K. N., Hotte, S. J., Yu, E. Y., Tu, D., Eigl, B. J., Tannock, I. F., Fred Saad, C., North, S. A., Powers, J., Gleave, M. E., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.8771 · Cited by 235 · see citing works

β+ Thalassemia: Aberrant splicing results from a single point mutation in an intron

Busslinger, M., Moschonas, N., & Flavell, R. A. (1981) · Cell · doi:10.1016/0092-8674(81)90412-8 · Cited by 229 · see citing works

Base substitution in an intervening sequence of a beta+-thalassemic human globin gene.

Spritz, R. A., Jagadeeswaran, P., Choudary, P. V., Biro, P. A., Elder, J. T., deRiel, J. K., Manley, J. L., Gefter, M. L., Forget, B. G., & Weissman, S. M. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2455 · Cited by 227 · see citing works

Antisense Drug Technology: Principles, Strategies, and Applications

Szymkowski, D. E. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02123-7 · Cited by 221 · see citing works

Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides

Wilton, S. D., Lloyd, F., Carville, K. S., Fletcher, S., Honeyman, K., Agrawal, S., & Kole, R. (1999) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00010-3 · Cited by 214 · see citing works

Advanced antisense therapies for postexposure protection against lethal filovirus infections

Warren, T. K., Warfield, K. L., Wells, J., et al. (2010) · Nature Medicine · doi:10.1038/nm.2202 · Cited by 203 · see citing works

Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides

Taylor, J. K., Zhang, Q. Q., Wyatt, J. R., & Dean, N. M. (1999) · Nature Biotechnology · doi:10.1038/15079 · Cited by 197 · see citing works

Stability of Cell-Penetrating Peptide−Morpholino Oligomer Conjugates in Human Serum and in Cells

Youngblood, D. S., Hatlevig, S. A., Hassinger, J. N., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060138s · Cited by 181 · see citing works

Site-specific excision from RNA by RNase H and mixed-phosphate-backbone oligodeoxynucleotides.

Agrawal, S., Mayrand, S. H., Zamecnik, P. C., et al. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1401 · Cited by 180 · see citing works

In vivo comparison of 2′‐O‐methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping

Heemskerk, H., de Winter, C. L., de Kimpe, S. J., van Kuik‐Romeijn, P., Heuvelmans, N., Platenburg, G. J., van Ommen, G. B., van Deutekom, J. C. T., & Aartsma-Rus, A. M. (2009) · The Journal of Gene Medicine · doi:10.1002/jgm.1288 · Cited by 173 · see citing works

Modification of Alternative Splicing of Bcl-x Pre-mRNA in Prostate and Breast Cancer Cells

Mercatante, D. R., Bortner, C. D., Cidlowski, J. A., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009256200 · Cited by 164 · see citing works

Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy kobe.

Matsuo, M., Masumura, T., Nishio, H., et al. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115244 · Cited by 156 · see citing works

Targeting RNA to treat neuromuscular disease

Francesco Muntoni, A., & Wood, M. J. A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3459 · Cited by 154 · see citing works

Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model

Heemskerk, H., de Winter, C., van Kuik‐Romeijn, P., Heuvelmans, N., Sabatelli, P., Rimessi, P., Braghetta, P., van Ommen, G. B., de Kimpe, S. J., Ferlini, A., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.72 · Cited by 141 · see citing works

Oligonucleotide-Mediated Survival of Motor Neuron Protein Expression in CNS Improves Phenotype in a Mouse Model of Spinal Muscular Atrophy

Williams, J. H., Schray, R. C., Patterson, C. A., Ayitey, S., Tallent, M. K., & Lutz, G. J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0950-09.2009 · Cited by 139 · see citing works

LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)

Agarwala, S. S., Keilholz, U., Gilles, E. M., Bedikian, A. Y., Wu, J., Kay, R., Stein, C. A., Itri, L. M., Suciu, S., & Eggermont, A. M. M. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.04.016 · Cited by 138 · see citing works

Pip5 Transduction Peptides Direct High Efficiency Oligonucleotide-mediated Dystrophin Exon Skipping in Heart and Phenotypic Correction in mdx Mice

Yin, H., Saleh, A. F. A., Betts, C., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.79 · Cited by 136 · see citing works

Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino

Wu, B., Lu, P., Benrashid, E., et al. (2009) · Gene Therapy · doi:10.1038/gt.2009.120 · Cited by 131 · see citing works

Efficient and Persistent Splice Switching by Systemically Delivered LNA Oligonucleotides in Mice

Roberts, J., Palma, E., Sazani, P., Ørum, H., Cho, M., & Kole, R. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.017 · Cited by 114 · see citing works

Uncharged stereoregular nucleic acid analogs: 2. Morpholino nucleoade otigomers with carbamate internucleoside linkages

Stirchak, E. P., Summerton, J. E., & Weller, D. D. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6129 · Cited by 113 · see citing works

Prevention of Dystrophic Pathology in Severely Affected Dystrophin/Utrophin-deficient Mice by Morpholino-oligomer-mediated Exon-skipping

Goyenvalle, A., Babbs, A., Powell, D., Kole, R., Fletcher, S., Wilton, S. D., & Davies, K. E. (2009) · Molecular Therapy · doi:10.1038/mt.2009.248 · Cited by 107 · see citing works

Vitravene™—Another Piece in the Mosaic

Crooke, S. T. (1998) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1998.8.vii · Cited by 96 · see citing works

Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers†

Jearawiriyapaisarn, N., Moulton, H. M., Sazani, P., et al. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp335 · Cited by 85 · see citing works

The therapeutic potential of antisense-mediated exon skipping.

van Ommen, G. J., van Deutekom, J., & Aartsma-Rus, A. M. (2008) · PubMed · Cited by 82 · see citing works

A Common Human β Globin Splicing Mutation Modeled in Mice

Lewis, J., Yang, B., Kim, R., et al. (1998) · Blood · doi:10.1182/blood.v91.6.2152 · Cited by 81 · see citing works

Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patient

Takeshima, Y., Wada, H., Yagi, M., et al. (2001) · Brain and Development · doi:10.1016/s0387-7604(01)00326-6 · Cited by 80 · see citing works

RNA repair restores hemoglobin expression in IVS2–654 thalassemic mice

Svasti, S., Suwanmanee, T., Fucharoen, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812436106 · Cited by 79 · see citing works

Phase III randomised study of dexamethasone with or without oblimersen sodium for patients with advanced multiple myeloma

Chanan-Khan, A. A., Niesvizky, R., Hohl, R. J., Zimmerman, T. M., Christiansen, N. P., Schiller, G. J., Callander, N. S., LISTER, J. W., Oken, M. M., & Jagannath, S. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190902748971 · Cited by 74 · see citing works

Variations in Amino Acid Composition of Antisense Peptide-Phosphorodiamidate Morpholino Oligomer Affect Potency against Escherichia coli In Vitro and In Vivo

Mellbye, B. L., Puckett, S. E., Tilley, L. D., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00917-08 · Cited by 73 · see citing works

Stabilization of Expanded (CTG)•(CAG) Repeats by Antisense Oligonucleotides

Nakamori, M., Gourdon, G., & Thornton, C. A. (2011) · Molecular Therapy · doi:10.1038/mt.2011.191 · Cited by 72 · see citing works

Therapeutic Oligonucleotides

Goodchild, J. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-188-8_1 · Cited by 70 · see citing works

Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis

Geller, B. L., Deere, J. D., Tilley, L. D., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki129 · Cited by 63 · see citing works

Basic peptide-morpholino oligomer conjugate that is very effective in killing bacteria by gene-specific and nonspecific modes

Wesolowski, D., Tae, H. S., Gandotra, N., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112561108 · Cited by 62 · see citing works

An Endogenous TNF-α Antagonist Induced by Splice-switching Oligonucleotides Reduces Inflammation in Hepatitis and Arthritis Mouse Models

Graziewicz, M. A., Tarrant, T. K., Buckley, B. K., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.85 · Cited by 61 · see citing works

Pegaptanib sodium for the treatment of neovascular age-related macular degeneration

Moshfeghi, A. A., & Puliafito, C. A. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.5.671 · Cited by 60 · see citing works

Phase II Trial of OGX-011 in Combination with Docetaxel in Metastatic Breast Cancer

Chia, S., Dent, S. F., Ellard, S. L., Ellis, P. M., Vandenberg, T. A., Gelmon, K. A., Powers, J., Walsh, W., Seymour, L., & Eisenhauer, E. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1159 · Cited by 59 · see citing works

RNA-Based Therapeutics: Ready for Delivery?

Bonetta, L. P. (2009) · Cell · doi:10.1016/j.cell.2009.02.010 · Cited by 57 · see citing works

Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus

Gabriel, G., Nordmann, A., Stein, D. A., et al. (2008) · Journal of General Virology · doi:10.1099/vir.0.83449-0 · Cited by 56 · see citing works

Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomers

Lupfer, C. R., Stein, D. A., Mourich, D. V., et al. (2008) · Archives of Virology · doi:10.1007/s00705-008-0067-0 · Cited by 53 · see citing works

Inhibition of Respiratory Syncytial Virus Infections With Morpholino Oligomers in Cell Cultures and in Mice

Lai, S., Stein, D. A., Guerrero-Plata, A., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.81 · Cited by 53 · see citing works

Cationic phosphorodiamidate morpholino oligomers efficiently prevent growth of Escherichia coli in vitro and in vivo

Mellbye, B. L., Weller, D. D., Hassinger, J. N., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp392 · Cited by 53 · see citing works

Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomers

Paessler, S., Rijnbrand, R. C. A., Stein, D. A., Ni, H., Yun, N. E., Dziuba, N., Borisevich, V., Seregin, A. V., Ma, Y., Blouch, R. E., et al. (2008) · Virology · doi:10.1016/j.virol.2008.03.032 · Cited by 49 · see citing works

Inactivation of expression of several genes in a variety of bacterial species by EGS technology

Shen, N., Ko, J.-H., Xiao, G., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903491106 · Cited by 46 · see citing works

A Morpholino Oligomer Targeting Highly Conserved Internal Ribosome Entry Site Sequence Is Able To Inhibit Multiple Species of Picornavirus

Stone, J. K., Rijnbrand, R. C. A., Stein, D. A., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00011-08 · Cited by 45 · see citing works

Safety Pharmacology and Genotoxicity Evaluation of AVI-4658

Sazani, P., Weller, D. L., & Shrewsbury, S. B. (2010) · International Journal of Toxicology · doi:10.1177/1091581809359206 · Cited by 41 · see citing works

Inhibition of gene expression by RNase P

Lundblad, E. W., & Altman, S. (2010) · New Biotechnology · doi:10.1016/j.nbt.2010.03.003 · Cited by 36 · see citing works

Is RNAi Dead?

Krieg, A. Μ. (2011) · Molecular Therapy · doi:10.1038/mt.2011.94 · Cited by 32 · see citing works

Correction of β654-thalassaemia mice using direct intravenous injection of siRNA and antisense RNA vectors

Xie, S., Li, W., Ren, Z., Huang, S., Zeng, F., & Zeng, Y. (2011) · International Journal of Hematology · doi:10.1007/s12185-010-0727-1 · Cited by 28 · see citing works

The thalassaemia syndromes

Higgs, D. R. (1993) · QJM · doi:10.1093/oxfordjournals.qjmed.a068846 · Cited by 19 · see citing works

Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers

Eide, K., Moerdyk-Schauwecker, M. J., Stein, D. A., et al. (2010) · Antiviral Therapy · doi:10.3851/imp1694 · Cited by 18 · see citing works

Alternative for Anti-TNF Antibodies for Arthritis Treatment

Paquet, J., Henrionnet, C., Pinzano, A., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.156 · Cited by 15 · see citing works

Engineered External Guide Sequences Effectively Block Viral Gene Expression and Replication in Cultured Cells

Jiang, X., Bai, Y., Rider, P. J. F., Kim, K., Zhang, C., Lu, S., & Liu, F. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158857 · Cited by 13 · see citing works

Genentech grapples with direct offer

Huggett, B. (2009) · Nature Biotechnology · doi:10.1038/nbt0309-212 · Cited by 10 · see citing works

Roche Exits RNAi Field, Cuts 4800 Jobs

Couzin-Frankel, J. (2010) · Science · doi:10.1126/science.330.6008.1163 · Cited by 10 · see citing works

Splice Switching Oligonucleotides as Potential Therapeutics

Sazani, P., Graziewicz, M. A., & Kole, R. (2007) · CRC Press eBooks · doi:10.1201/9780849387951.ch4 · Cited by 7 · see citing works

Bacteriocins—A viable alternative to antibiotics?

Cotter, P. D., Ross, R. P., & Hill, C. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2937 · Cited by 1,793 · see citing works

MDM2, MDMX and p53 in oncogenesis and cancer therapy

Wade, M., Li, Y.-C., & Wahl, G. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3430 · Cited by 1,279 · see citing works

KRAS Mutation: From Undruggable to Druggable in Cancer

Huang, L., Guo, Z., Wang, F., & Fu, L. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00780-4 · Cited by 1,127 · see citing works

Phosphorothioates, Essential Components of Therapeutic Oligonucleotides

Eckstein, F. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2014.0506 · Cited by 684 · see citing works

Iron metabolism in the CNS: implications for neurodegenerative diseases

Rouault, T. A. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3453 · Cited by 496 · see citing works

Exosomes are natural carriers of exogenous siRNA to human cells in vitro

Shtam, T. A., Kovalev, R. A., Varfolomeeva, E. Y., Makarov, E. M., Kil, Y. V., & Filatov, M. V. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-88 · Cited by 499 · see citing works

Long Noncoding RNA in Cancer: Wiring Signaling Circuitry

Lin, C., & Yang, L. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.11.008 · Cited by 488 · see citing works

Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases

Wu, Y.-Y., & Kuo, H.-C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00636-z · Cited by 213 · see citing works

Targeting KRAS-dependent tumors with AZD4785, a high-affinity therapeutic antisense oligonucleotide inhibitor of KRAS

Ross, S. J., Revenko, A. S., Hanson, L. L., Ellston, R., Staniszewska, A., Whalley, N., Pandey, S. K., Revill, M., Rooney, C., Buckett, L. K., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal5253 · Cited by 177 · see citing works

Gene therapy for lipoprotein lipase deficiency

Gaudet, D., Méthot, J., & Kastelein, J. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283555a7e · Cited by 178 · see citing works

Collateral lethality: a new therapeutic strategy in oncology

Muller, F. L., Aquilanti, E. A., & DePinho, R. A. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.10.002 · Cited by 132 · see citing works

Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides

Hinrich, A. J., Jodelka, F. M., Chang, J. L., Brutman, D., Bruno, A. M., Briggs, C. A., James, B. D., Stutzmann, G. E., Bennett, D. A., Miller, S. A., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505846 · Cited by 127 · see citing works

Resolving subcellular miRNA trafficking and turnover at single-molecule resolution

Pitchiaya, S., Heinicke, L. A., Park, J. I., Cameron, E. L., & Walter, N. G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.075 · Cited by 98 · see citing works

Therapeutic reversal of Huntington’s disease by <i>in vivo</i> self-assembled siRNAs

Zhang, L., Wu, T., Shan, Y., Li, G., Ni, X., Chen, X., Hu, X., Lin, L., Li, Y., Guan, Y., et al. (2021) · Brain · doi:10.1093/brain/awab354 · Cited by 97 · see citing works

RNA delivery biomaterials for the treatment of genetic and rare diseases

Zhao, W., Hou, X., Vick, O. G., & Dong, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119291 · Cited by 82 · see citing works

Mutation of nucleotides around the +1 position of type 3 polymerase III promoters: The effect on transcriptional activity and start site usage

Gao, Z., Harwig, A., Berkhout, B., & Herrera-Carrillo, E. (2017) · Transcription · doi:10.1080/21541264.2017.1322170 · Cited by 47 · see citing works

Structural components for amplification of positive and negative strand VEEV splitzicons

Blakney, A. K., McKay, P. F., & Shattock, R. J. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00071 · Cited by 47 · see citing works

Dysfunctional heteroreceptor complexes as novel targets for the treatment of major depressive and anxiety disorders

Pérez de la Mora, M., Borroto-Escuela, D. O., Crespo-Ramírez, M., Rejón-Orantes, J. D. C., Palacios-Lagunas, D. A., Martínez-Mata, M. K., Sánchez-Luna, D., Tesoro-Cruz, E., & Fuxe, K. (2022) · Cells · doi:10.3390/cells11111826 · Cited by 21 · see citing works

Can siRNA Technology Provide the Tools for Gene Therapy of the Future?

Hamar, P., & Rácz, Z. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777935186 · Cited by 34 · see citing works

Visualizing a Correlation between siRNA Localization, Cellular Uptake, and RNAi in Living Cells

Chiu, Y., Ali, A., Chu, C., Cao, H., & Rana, T. M. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.06.006 · Cited by 381 · see citing works

RNA interference and tumor gene therapy

Hai, S. (2009)

RNA interference and small interference RNA

Qian, K. (2005) · Journal of Zhejiang University(Engineering Science)

RNA interference and its application in tumor

Zhang, H. (2004) · Journal of Jinan University